Impact of COVID-19 Lockdown in Eating Disorders: A Multicentre Collaborative International Study
Isabel Baenas(Institut d'Investigació Biomédica de Bellvitge), Denis Gubin(Institute for Biomedicine), Gemma Mestre‐Bach(Universidad Internacional De La Rioja), Mar Carceller‐Sindreu(Universitat Autònoma de Barcelona), María Teresa Plana(Instituto de Salud Carlos III), Jéssica Sánchez‐González(Bellvitge University Hospital), Gema Frühbeck(Instituto de Salud Carlos III), Alba Andreu(Consorci Institut D'Investigacions Biomediques August Pi I Sunyer), Ia Shekriladze(Ilia State University), Maria Eulalia Loran-Meler(Hospital Universitari Germans Trias i Pujol), Mikhail F. Borisenkov(Ural Branch of the Russian Academy of Sciences), Andreas Karwautz(Universitätsklinik für Kinder und Jugendpsychiatrie), Teresa Rangil(Hospital Universitari Germans Trias i Pujol), Laurence Claes(University of Antwerp), Paulo P. P. Machado(University of Minho), Angela Favaro(University of Padua), Andrés Gómez del Barrio(Instituto de Salud Carlos III), Roser Granero(Universitat Autònoma de Barcelona), Carlos Diéguez(Spanish Biomedical Research Centre in Physiopathology of Obesity and Nutrition), Jordi Carratalà(Instituto de Salud Carlos III), Kate Tchanturia(King's College London), Lucero Munguía(Bellvitge University Hospital), Isabel Sánchez(Institut d'Investigació Biomédica de Bellvitge), Bea Pászthy(Semmelweis University), Ana R. Sepúlveda(Universidad Autónoma de Madrid), Meritxell Lozano(Fidmag Sisters Hospitallers), Daniel Le Grange(University of California, San Francisco), Francisco J. Tinahones(Instituto de Salud Carlos III), Jose Soriano‐Pacheco(Universitat Autònoma de Barcelona), Raquel Cecilia‐Costa(Hospital Sant Joan de Déu Barcelona), Michael D. Zeiler(Medical University of Vienna), Jana Gricová(Charles University), Ferenc Túry(Semmelweis University), Dan J. Stein(University of Cape Town), Hana Papežová(Charles University), Annika Zanko(Werner-Wicker-Klinik), Brigita Bax(Vilnius University), Carlota Gudiol(Instituto de Salud Carlos III), Anders Håkansson(Lund University), Raquel Linares(Fidmag Sisters Hospitallers), Mikel Etxandi(Bellvitge University Hospital), Eduardo Serrano‐Troncoso(Hospital Sant Joan de Déu Barcelona), José Manuel Fernández‐Real(Spanish Biomedical Research Centre in Physiopathology of Obesity and Nutrition), Sergey V. Popov(Russian Academy of Sciences), Rosa Navarrete(Universidad Autónoma de Madrid), Violeta L. Moizé(Centro de Investigación Biomédica en Red Diabetes y Enfermedades Metabólicas Asociadas), Hartmut Imgart(Werner-Wicker-Klinik), Montserrat Graell(Instituto de Salud Carlos III), David González-Parra(Universidad de Salamanca)
Cited by 34
Related Papers
Prevalence, incidence and mortality from cardiovascular disease in patients with pooled and specific severe mental illness: a large‐scale meta‐analysis of 3,211,768 patients and 113,383,368 controls
|World Psychiatry|2017|1.7k
Metformin alters the gut microbiome of individuals with treatment-naive type 2 diabetes, contributing to the therapeutic effects of the drug
|Nature Medicine|2017|1.6k
EASL–EASD–EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD)
|Journal of Hepatology|2024|1.6k
Definition and diagnostic criteria of clinical obesity
|The Lancet Diabetes & Endocrinology|2025|1.5k
Posttraumatic stress disorder in the World Mental Health Surveys
|Psychological Medicine|2017|1.4k